Where is Belle located?

Belle is headquartered in Cambridge, United States.

How many employees does Belle have?

As of May 31, 2026, the latest employee count at Belle is 44.

Is Belle a funded company?

Belle is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Belle rank among its competitors?

Belle ranks 4th amongst 41 active competitors, of which 5 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Skin Analytics, which secured $19.8M in Apr, 2025.

Who are the top competitors of Belle?

Belle's top competitors include Skin Analytics, Haut and PathologyWatch. Among them, Skin Analytics secured the most recent funding round in April, 2025.

Belle - 2026 Company Profile, Funding & Competitors

Belle is a funded company based in Cambridge (United States), founded in 2017. It operates as an Online platform for monitoring multiple skin conditions. The company has 41 active competitors, including 5 funded and 3 that have exited. Its top competitors include companies like Skin Analytics, Haut and PathologyWatch.

Company Details

Online platform for monitoring multiple skin conditions. The platform utilizes AI technology to identify the different skin conditions such as Acne, Psoriasis, skin cancer, vitiligo, eczema, and others. Users can upload the picture and identify the skin condition/severity through the score.

Website: www.belle.ai/
Email ID: *****@belle.ai
Phone Number: +1 **********

Key Metrics

Founded Year

2017

Location

Cambridge, United States

Stage

Funding Raised

Investors

Lifeforce Capital

Ranked

4^th among 41 active competitors

Employee Count

44 as on May 31, 2026

Similar Companies

Innovaccer & 2319 more

View Belle's full profile

Belle is a funded company. Belle has 1 institutional investor.

View details of Belle's funding rounds and investors

Belle's employee count trend

Belle has 44 employees as of May 26. Here is Belle's employee count trend over the years:

Uncover Belle's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Belle include Skin Analytics, Haut and PathologyWatch. Here is the list of Top 10 competitors of Belle, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Skin Analytics 2012, London (United Kingdom), Series B	Provider of smartphone based skin cancer detection	$32.6M	Intrepid Growth Partners, Hoxton Ventures ... & 258 others	58/100
2nd	Haut 2017, Tallinn (Estonia), Seed	Provider of SaaS-based solutions for skincare businesses	$2.15M	LongeVC, JLABS & 2 others	55/100
3rd	PathologyWatch 2018, Salt Lake City (United States), Acquired	Provider of clinical workflow management and decision making software and services for professionals	$34.3M	Ceros Capital Markets, Rock Creek Capital ... & 17 others	53/100
4th	Belle 2017, Cambridge (United States), Funding Raised	Online platform for monitoring multiple skin conditions	-	Lifeforce Capital	52/100
5th	3Derm 2012, New Haven (United States), Acquired	Digital skin image analysis and disease detection tool for providers	$2.8M	Philips HealthWorks, Zaffre Investments & 10 others	44/100
6th	Nia Health 2019, Berlin (Germany), Seed	Provider of digital therapeutics for personalized patient support in dermatology and allergology	$3.75M	HTGF, adesso ventures & 5 others	37/100
7th	Love My Delta 2020, Philadelphia (United States), Seed	AI-based skin analysis tool for wellness, beauty, and aesthetic medicine	$3.17M	-	36/100
8th	Crisalix 2008, Lausanne (Switzerland), Acquired	Platform offering a virtual reality 4D and 3D plastic and cosmetic surgery simulator	-	Remora Capital	35/100
9th	Nurithmlabs 2018, Noida (India), Seed	Provider of AI-based decision support tool for dermatologists	$23.4K	Social Alpha, C-CAMP & 3 others	32/100
10th	NextMotion 2014, Saint Mande (France), Unfunded	Device for capturing before and after pictures of patients for dermatology analysis	-	-	27/100